Thyroid Iodine (Child)

Nuclear Med offers a wide variety of studies. The majority of studies require the patient to be injected with a radioactive isotope.

Depending on the study there might be a waiting time before the scan (allowing the isotope enough time to gather in the particular study site). The patient will then be scanned at least once, depending on the study. Please note: a number of the appointment will require patients to return to Nuclear Med repeatedly for up to two days. Please familiarise yourself with the requirements as the radioactive isotopes have sepcific window periods in which they can be scanned

loading...

Thyroid Iodine (Child)

Preparation for scan is required. Please contact our practice.

Iodinated MIBG (I-123) is concentrated in the adrenal medulla and while the quantity taken up is insufficient to image normal adrenals, in patients with phaeochromocytoma, neuroblastoma, and adrenal medullary hyperplasia, uptake is much higher. Imaging with I-123 MIBG may also be used to assess uptake prior to therapy with much larger quantities. The patient's thyroid must be blocked with potassium iodide prior to administration of the radiopharmaceutical. Imaging is generally commenced 24 hours after administration and may be repeated at 48 and 72 hours.

Used to assess:

The function of an infant’s Thyroid gland to determine whether it is over or under active. Phaeochromocytoma Neuroblastoma Adrenal medullary hyperplasia

Phone our practice

contact details

How to book

Patients will need to be referred to Nuclear Med by a referring doctor. Patients must select the specific scan/study required by their referring doctor and book an appointment at the most convenient location.

Checklist:

Medical aid authorisation (referring doctor to provide patient with specific ICD 10 code for medical aid authorisation)
Referring doctor’s name and practice number
Newly diagnosed oncology patients may need to register for oncology (referring doctor to facilitate registration)